HHS selects Mayo Clinic physician to chair advisory council on Alzheimer's

Ronald Petersen, M.D., Cadieux Director of the Mayo Alzheimer's Disease Research Center and the Mayo Clinic Study of Aging, was selected to chair the Advisory Council on Alzheimer's Research, Care, and Services. The group was announced by Health and Human Services (HHS) Secretary Kathleen Sebelius.

The 12 non-federal council members include Alzheimer's disease patient advocates, caregivers and health care providers. They will advise the secretary on federal programs that impact people with Alzheimer's disease and related dementia.

"This is an important opportunity to have a significant impact on the federal Alzheimer's disease initiatives and to develop a plan to address issues surrounding the disease," Dr. Petersen says. "I look forward to working with Secretary Sebelius and the rest of the Advisory Council. Collaboration has guided patient care, research and education at Mayo Clinic for more than a century and will serve an important role here."

Alzheimer's disease affects 5.1 million Americans and is expected to impact more than 20 million people in the U.S. by 2050. Mayo Clinic researchers are pushing to identify individuals at the earliest stage of Alzheimer's disease to try to prevent cognitive impairment.

The advisory council, announced by HHS on Tuesday, will meet quarterly to help develop a national plan involving HHS, Veterans Affairs, the Department of Defense and the National Science Foundation. The council is required by the National Alzheimer's Project Act. Its members will serve four-year terms.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Patient-derived organoids: Transforming cancer research and personalized medicine